Details for New Drug Application (NDA): 021395

✉ Email this page to a colleague

NDA 021395 describes SPIRIVA, which is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from two suppliers. There are six patents protecting this drug and one Paragraph IV challenge. Additional details are available on the SPIRIVA profile page.

The generic ingredient in SPIRIVA is tiotropium bromide. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the tiotropium bromide profile page.

Summary for 021395

Tradename:	SPIRIVA
Applicant:	Boehringer Ingelheim
Ingredient:	tiotropium bromide
Patents:	1

Pharmacology for NDA: 021395

Mechanism of Action	Cholinergic Antagonists

Medical Subject Heading (MeSH) Categories for 021395

Bronchodilator Agents
Cholinergic Antagonists
Parasympatholytics

Suppliers and Packaging for NDA: 021395

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
SPIRIVA	tiotropium bromide	POWDER;INHALATION	021395	NDA	Boehringer Ingelheim Pharmaceuticals, Inc.	0597-0075	0597-0075-41	3 BLISTER PACK in 1 CARTON (0597-0075-41) / 10 CAPSULE in 1 BLISTER PACK
SPIRIVA	tiotropium bromide	POWDER;INHALATION	021395	NDA	Boehringer Ingelheim Pharmaceuticals, Inc.	0597-0075	0597-0075-47	9 BLISTER PACK in 1 CARTON (0597-0075-47) / 10 CAPSULE in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	POWDER;INHALATION			Strength	EQ 0.018MG BASE/INH
Approval Date:	Jan 30, 2004	TE:	AB	RLD:	Yes
Patent:	8,022,082*PED	Patent Expiration:	Jul 19, 2026	Product Flag?		Substance Flag?		Delist Request?	Y

Expired US Patents for NDA 021395

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Boehringer Ingelheim	SPIRIVA	tiotropium bromide	POWDER;INHALATION	021395-001	Jan 30, 2004	7,642,268*PED	⤷ Get Started Free
Boehringer Ingelheim	SPIRIVA	tiotropium bromide	POWDER;INHALATION	021395-001	Jan 30, 2004	5,478,578	⤷ Get Started Free
Boehringer Ingelheim	SPIRIVA	tiotropium bromide	POWDER;INHALATION	021395-001	Jan 30, 2004	RE38912*PED	⤷ Get Started Free
Boehringer Ingelheim	SPIRIVA	tiotropium bromide	POWDER;INHALATION	021395-001	Jan 30, 2004	RE39820*PED	⤷ Get Started Free
Boehringer Ingelheim	SPIRIVA	tiotropium bromide	POWDER;INHALATION	021395-001	Jan 30, 2004	7,309,707*PED	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.